NHPNational Healthcare Properties, Inc.(NHP)Stock Analysis

AI analysis on 2,800+ stocks →
Real EstateNasdaq
Institutional-grade research for retail investors
SEC EDGAR: CIK 1561032NHP stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 5 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

NHP Stock Analysis & AI Quality Score

AI stock analysis and institutional research for National Healthcare Properties, Inc. (NHP), a Real Estate sector company. NHP is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 5 institutional filers currently hold this stock. Based on the latest XBRL financial filings (Q1 2026), National Healthcare Properties, Inc. reports quarterly revenue of $86.3M, net income of $-4.3M, an operating margin of 11.7%. Top institutional holders of NHP by reported 13-F value include Financial Gravity Asset Management,, NBC SECURITIES,, RETIREMITTEN FINANCIAL, based on the most recent SEC filings. NHP trades on the Nasdaq exchange and files with the SEC under CIK 1561032. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NHP daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for National Healthcare Properties, Inc. directly from SEC EDGAR.

Revenue

Q1 2026

$86.3M

Net Income

Q1 2026

$-4.3M

Free Cash Flow

Q1 2026

$9.0M

Operating Margin

Q1 2026

11.7%

ROIC

Q1 2026

1.7%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-3.3% YoY
$342.3MFY 2025
FY21 $329.4MFY22 $335.8MFY24 $353.8MFY25 $342.3M

Net Income

FY 2025
FY21 FY22 FY24 FY25

Operating Income

+102.7% YoY
$3.3MFY 2025
FY21 $-37.4MFY22 $-31.5MFY24 $-123.5MFY25 $3.3M

EPS (Diluted)

+65.1% YoY
$-2.51FY 2025
FY21 $-0.81FY22 $-0.82FY24 $-7.19FY25 $-2.51

Total Assets

-12.0% YoY
$1.71BFY 2025
FY21 $2.21BFY22 $2.18BFY24 $1.95BFY25 $1.71B

Op. Cash Flow

+108.7% YoY
$7.0MFY 2025
FY21 $38.9MFY22 $28.3MFY24 $-79.8MFY25 $7.0M

AI Insight: NHP Financial Trends

NHP stabilized operating income near breakeven while reducing debt by $165M year-over-year, but revenue remains under pressure.

Operating income swung from -$100M loss in Q2 2024 to $10M profit in Q1 2026, signaling operational turnaround.

Total debt fell from $757M (Q2 2024) to $592M (Q1 2026), reducing leverage by 22% over eight quarters.

Revenue declined steadily from $89M in Q2 2024 to $84M in Q4 2025, recovering only slightly to $86M in Q1 2026.

Operating income remains volatile: $10M profit in Q1 2026 follows $-7M loss in prior quarter and $2M in Q3 2025.

Operating cash flow inconsistent; swung $-95M to $6M to $10M range, limiting visibility into cash generation sustainability.

AI Insight: NHP Ratio Trends

NHP's profitability remains volatile and deeply negative over the trailing twelve months, with Q1 2026 showing only marginal recovery from a loss-making cycle.

Operating margin swung from -7.8% in Q4 2025 to +11.7% in Q1 2026; ROIC improved correspondingly to 6.8% from -4.4%.

TTM operating margin and ROIC remain near breakeven (0.1% and 0.1%) despite Q1 2026 gains, reflecting persistent losses in prior quarters.

Quarterly results exhibit extreme volatility: margins ranged from -113.1% (Q2 2024) to +15.1% (Q1 2025), indicating structural instability.

TTM profitability barely positive—any setback risks return to persistent losses. Sustainability of Q1 2026 margin is unproven.

Missing ROE, ROA, and leverage data limits full capital structure and shareholder return assessment.

Get alerted when NHP's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for National Healthcare Properties, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put NHP on your watchlist

Track score changes the day National Healthcare Properties, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is NHP a good stock to buy?

13F Pro's AI-powered analysis of National Healthcare Properties, Inc. (NHP) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Real Estate sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NHP are available on the NHP stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own NHP?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NHP. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of National Healthcare Properties, Inc.'s investment landscape.